We monitor all patients carefully
Monitor blood glucose in patients with diabetes Acute Kidney Injury Due to Volume Depletion: There have been postmarketing reports of acute kidney injury, in some cases requiring hemodialysis, in patients treated with semaglutide
Novo Nordisks once-daily oral Wegovy (25 mg semaglutide) is now approved for adults with obesity, or overweight patients with at least one weight-related condition, marking the first pill-based GLP-1 option indicated for both weight loss and cardiovascular risk reduction
Their use should be individualised, considering patient-specific profiles and other potential risks, in line with a precision psychiatry approach
If your interest is energy rather than skin tone, a simpler and better studied option may fit you, such as our approach to B12 shots that support energy when you are genuinely deficient, and why testing comes first
This order-to-receipt step is where the Sourced Peptides listing can be most useful